Scarica l'app Stockscreener
4.22
3.94%
0.16
Dopo l'orario di chiusura:
4.09
-0.13
-3.08%
Precedente Chiudi:
$4.06
Aprire:
$4.03
Volume 24 ore:
65,399
Relative Volume:
0.04
Capitalizzazione di mercato:
$9.08M
Reddito:
$3.50M
Utile/perdita netta:
$-37.33M
Rapporto P/E:
-4.22
EPS:
-1
Flusso di cassa netto:
$-19.15M
1 W Prestazione:
+4.71%
1M Prestazione:
-24.51%
6M Prestazione:
-54.03%
1 anno Prestazione:
-79.43%
Intervallo 1D:
$4.00
$4.29
Intervallo di 1 settimana:
$4.00
$4.88
Portata 52W:
$2.77
$100.80
Hcw Biologics Inc Stock (HCWB) Company Profile
Nome
Hcw Biologics Inc
Settore
Industria
Telefono
954-842-2024
Indirizzo
2929 N COMMERCE PKWY, MIRAMAR
Confronta HCWB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
4.22 | 8.74M | 3.50M | -37.33M | -19.15M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Hcw Biologics Inc Borsa (HCWB) Ultime notizie
Is HCW Biologics Inc. a candidate for recovery playTrend Reversal & Safe Capital Allocation Plans - newser.com
HCW Biologics Inc. stock volume spike explainedWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
Will HCW Biologics Inc. outperform the marketWeekly Volume Report & Entry Point Confirmation Signals - newser.com
Can HCW Biologics Inc. recover in the next quarterBear Alert & Safe Entry Point Identification - newser.com
Volume spikes in HCW Biologics Inc. stock – what they meanJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Will HCW Biologics Inc. stock benefit from green energy trendsJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
HCW Biologics (NASDAQ:HCWB) Shares Up 21.1% – Time to Buy? - Defense World
HCW Biologics (NASDAQ:HCWB) Trading Up 21.1% – Should You Buy? - Defense World
Historical volatility pattern of HCW Biologics Inc. visualized2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
What drives HCW Biologics Inc stock priceVolume Analysis Techniques & Small Budget Capital Gains - earlytimes.in
What MACD signals say about HCW Biologics Inc.Trade Volume Report & Weekly Return Optimization Alerts - newser.com
Earnings visualization tools for HCW Biologics Inc.2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
HCW Biologics Introduces Second-Generation T-Cell Engager Program with Enhanced Safety and Efficacy for Solid Tumors - Quiver Quantitative
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual - GlobeNewswire
What analysts say about HCW Biologics Inc stockBlue Chip Stock Analysis & Wealth Building Starts With One Click - Early Times
Fed Watch: What is the earnings history of HCW Biologics Inc2025 Buyback Activity & Verified Chart Pattern Signals - خودرو بانک
Can momentum traders help lift HCW Biologics Inc.July 2025 Fed Impact & Consistent Profit Alerts - newser.com
Can HCW Biologics Inc. hit a new high this month2025 Institutional Moves & Daily Chart Pattern Signals - newser.com
Should you hold or exit HCW Biologics Inc. nowQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Published on: 2025-09-20 08:29:13 - خودرو بانک
What’s next for HCW Biologics Inc. stock priceStop Loss & Long-Term Growth Stock Strategies - newser.com
Is HCW Biologics Inc. forming a reversal pattern2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - newser.com
Smart Money: Will HCW Biologics Inc. outperform the market in YEARJuly 2025 Summary & Consistent Return Strategy Ideas - خودرو بانک
Does HCW Biologics Inc. show high probability of reboundMarket Sentiment Report & Real-Time Market Sentiment Alerts - newser.com
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing - GlobeNewswire
What to expect from HCW Biologics Inc. in the next 30 daysWeekly Profit Summary & Safe Capital Investment Plans - newser.com
Macro Review: Can RLI Corp. reach resistance levels soonWeekly Risk Summary & Real-Time Stock Price Movement Reports - khodrobank.com
HCW Biologics Inc. stock trendline breakdownWeekly Risk Report & Growth-Oriented Investment Plans - newser.com
Aug Sentiment: Can HCW Biologics Inc. lead its sector in growth2025 Stock Rankings & Daily Profit Focused Stock Screening - خودرو بانک
Trade Report: Can HCW Biologics Inc stock double in the next yearCEO Change & Intraday High Probability Setup Alerts - خودرو بانک
Will HCW Biologics Inc. bounce back from current supportRate Hike & Fast Exit Strategy with Risk Control - newser.com
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program - ADVFN Ltd
How institutional ownership impacts HCW Biologics Inc. stock2025 Short Interest & Community Verified Trade Signals - newser.com
Growth Review: Is HCW Biologics Inc. stock good for income investorsDip Buying & Momentum Based Trading Signals - khodrobank.com
Hcw Biologics Inc Azioni (HCWB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hcw Biologics Inc Azioni (HCWB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
May 16 '25 |
Buy |
7.45 |
1,342 |
9,998 |
4,075 |
| GARRETT SCOTT T | Director |
May 16 '25 |
Buy |
7.45 |
13,423 |
100,001 |
25,505 |
| Winer Gary M | Director |
May 08 '25 |
Buy |
26.00 |
2,308 |
60,008 |
2,733 |
| Wong Hing C | Chief Executive Officer |
May 08 '25 |
Buy |
26.00 |
92,500 |
2,405,000 |
493,857 |
| GARRETT SCOTT T | Director |
May 08 '25 |
Buy |
26.00 |
5,385 |
140,010 |
12,082 |
| Byam Rebecca | Chief Financial Officer |
May 08 '25 |
Buy |
26.00 |
8,462 |
220,012 |
43,010 |
| Flowers Lee | SVP of Business Development |
May 08 '25 |
Buy |
26.00 |
962 |
25,012 |
5,720 |
| Greene Rick S. | Director |
May 08 '25 |
Buy |
26.00 |
962 |
25,012 |
2,066 |
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):